Clinical Trials on Insulin-Like Growth Factor I in United States
Total 99 results
-
Wright State UniversityRecruitingAging | UVB Phototherapy Burn | Insulin-like Growth Factor 1United States
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
IpsenTerminatedPrimary Insulin-like Growth Factor-1 DeficiencyUnited States
-
IpsenCompletedGrowth Disorders | Insulin-Like Growth Factor-1 DeficiencyUnited States
-
IpsenTerminatedrhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 DeficiencyInsulin-like Growth Factor-1 DeficiencyUnited States
-
Janssen Research & Development, LLCCompletedUrothelial Cancer | Receptors, Fibroblast Growth FactorUnited States, Italy, Belgium, United Kingdom, Japan, Turkey, Brazil, Ukraine, Spain, Russian Federation, Israel, France, Germany, Argentina
-
Azitra Inc.SuspendedPapulopustular Rosacea | Epidermal Growth FactorUnited States
-
State University of New York at BuffaloAmerican Egg BoardCompletedObesity | Metabolic Syndrome | Cardiovascular Risk Factor | Food Allergy | Growth & Development | Cognitive Developmental DelayUnited States
-
Catalyst BiosciencesTerminatedPrevious Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I DeficiencyUnited States
-
University of MinnesotaRecruitingGrowth Hormone Deficiency | Growth Hormone TreatmentUnited States
-
Oregon Health and Science UniversityCompletedGrowth Hormone DeficiencyUnited States
-
Nemours Children's ClinicThrasher Research FundCompleted
-
University Hospital BirminghamRecruitingAdult Growth Hormone DeficiencyUnited Kingdom
-
Vanderbilt University Medical CenterCompletedNormal Pressure HydrocephalusUnited States
-
University of MichiganCompletedGingival Recession | Platelet Derived Growth FactorUnited States
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Massachusetts General HospitalUnknownFetal Growth RetardationUnited States
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Washington University School of MedicineJanssen Scientific Affairs, LLCCompletedAdiposity | HIV I InfectionUnited States
-
Dompé Farmaceutici S.p.AWithdrawnType I DiabetesUnited States
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Northern Michigan UniversityRecruitingQuality of Life | Physical Inactivity | Lifestyle FactorsUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
University of ReadingBiotechnology and Biological Sciences Research Council; Unilever R&D; Foundation...CompletedCardiovascular Risk FactorsUnited Kingdom
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Pennington Biomedical Research CenterCompletedSleep Disturbance | Cardiovascular Risk Factor | Insulin Sensitivity | Postmenopausal SymptomsUnited States
-
University of California, DavisTouro University, CaliforniaCompletedMetabolic Syndrome | Cardiovascular Risk Factor | Insulin Sensitivity | Type2 Diabetes MellitusUnited States
-
University of VirginiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Insulin Resistance | Cardiovascular Risk FactorUnited States
-
Medical University of South CarolinaCompletedMetabolic Syndrome | Overweight and Obesity | Cardiovascular Risk FactorUnited States
-
Reshma L. Mahtani, D.O.Gilead SciencesRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Hormone-receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Low Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Center for Advancing Translational Sciences (NCATS)RecruitingGlioblastoma Multiforme | Epidermal Growth Factor Receptor | Glycolytic IndexUnited States
-
Dana-Farber Cancer InstituteAstellas Pharma IncTerminatedNon-Small Cell Lung Cancer | Epidermal Growth Factor ReceptorUnited States
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCRecruitingDoravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIVLipid Metabolism Disorders | Cardiovascular Risk Factor | HIV I InfectionUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Italy, Finland and more
-
University of California, San FranciscoJuvenile Diabetes Research FoundationCompletedType 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMUnited States, Australia
-
Nationwide Children's HospitalWithdrawn
-
M.D. Anderson Cancer CenterNot yet recruitingHormone Receptor-positive Human Epidermal Growth Factor 2-negative | Metastatic Invasive LObular CarcinomaUnited States
-
Montefiore Medical CenterAlbert Einstein College of Medicine; Deciphera Pharmaceuticals LLCTerminatedBreast Cancer | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Breast AdenocarcinomaUnited States
-
University of UtahRecruitingSleep | Type 2 Diabetes | Overweight and Obesity | Insulin Sensitivity | Time Restricted Feeding | Sleep Hygiene | Cardiometabolic Syndrome | Eating Habit | Lifestyle FactorsUnited States
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Duke UniversityCompletedQuality of Life | Pediatric Obesity | Childhood Obesity | Cardiovascular Risk FactorUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Boehringer Ingelheim; Robert H. Lurie Cancer...Active, not recruitingRecurrent Adult Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A | Fibroblast Growth Factor Basic Form Measurement | FLT3 Internal Tandem DuplicationUnited States
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States